Pear Therapeutics (US), Inc.

About Pear Therapeutics (US), Inc.

Pear Therapeutics develops and commercializes prescription digital therapeutics for substance use disorders, opioid use disorder, chronic insomnia, and related mental health conditions. FDA-cleared products include reSET, reSET-O, and Somryst, delivered through smartphone apps combined with clinician dashboards. The company uses software-based interventions to deliver cognitive behavioral therapy and contingency management, aiming to improve patient outcomes while generating real-world evidence. Pear partners with health systems, payers, and pharmaceutical companies to integrate digital treatments into standard care pathways and reimbursement models.